US to Pay Pfizer Nearly $2B for More Paxlovid Courses in 2023


Food and Drug Agency Worthy Christian news(Worthy News) – The U.S. government agreed to pay Pfizer Inc nearly $2 billion for an additional 3.7 million courses of its COVID-19 antiviral treatment Paxlovid, the company said on Tuesday.

The new purchase supplements the 20 million courses previously bought by the United States and are planned for delivery by early 2023, Pfizer said in a statement.

The Biden administration had previously agreed to pay around $10.6 billion – roughly $530 per treatment course – for the first 20 million courses it ordered. They are paying around the same amount per course under the new contract. [ Source: Newsmax (Read More…) ]

9
people are currently praying.

đź’ˇ Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.

📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌

Latest Worthy News

Senate Blocks FISA Surveillance Extension Amid Fight Over Trump Intelligence Pick
U.S. Economy Adds 172,000 Jobs in May, Far Exceeding Expectations
Iran Fires Missiles At Northern Israel After Israeli Strike On Hezbollah Command Center In Beirut
Armenians Vote In Crucial Election (Worthy News Focus)
Israel Strikes Hezbollah Command Centers in Beirut’s Dahiyeh After Fire From Lebanon
Slovenia Approves Pro-Israel Jansa Government, Signaling Policy Shift
Christian Officer Wins Settlement After Suspension Over Islam Questions
Students Risk Lives In Iran Protest Movement
Montenegro Moves Closer To EU Membership As Bloc Weighs Lessons From Hungary (Worthy News In-Depth)
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.

Worthy Christian News